> Three Russian doctors involved in clinical trials for GlaxoSmithKline have been charged with illegal practices, including failure to safeguard the health of infants. Report
> The FDA has approved a faster dosing schedule for GlaxoSmithKline's hepatitis vaccine Twinrix. Report
> Genelabs Technologies has reached agreement with the FDA on an SPA for a Phase III clinical trial of Prestara (prasterone) for lupus. Release
> Pharmexa and Affitech have inked a licensing deal on diabody technology. Release
> Scientists report Alzheimer's vaccine success. Report
> A group of researchers has identified genes that can help a person quit smoking. Report
> Using bacterial enzymes, an international team of researchers have developed a simple method to convert type A, B or AB to group O blood that can be used universally. Report
And Finally... A $750,000 grant will allow a University of Kentucky researcher to take a therapy for macular degeneration into the clinic. Report